Yang Cao's most recent trade in Humacyte Inc was a trade of 283,101 Stock Options (right to buy) done . Disclosure was reported to the exchange on Jan. 21, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Humacyte Inc | Yang Cao | Chief Regulatory Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 283,101 | 283,101 | - | - | Stock Options (right to buy) | |
Humacyte Inc | Yang Cao | Chief Regulatory Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2023 | 210,000 | 210,000 | - | - | Stock Options (right to buy) | |
Humacyte Inc | Yang Cao | Chief Regulatory Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Sep 2022 | 145,000 | 145,000 | - | - | Stock Options (right to buy) |